The Carcinogenicity of r-Propiolactone for Mouse-Skin
1956
The Carcinogenicity of Beta-Propiolactone for Mouse Skin
Sample size: 32
publication
Evidence: moderate
Author Information
Author(s): F. J. C. Roe, O. M. Glendenning
Primary Institution: Cancer Research Department, London Hospital Medical College
Hypothesis
Is beta-propiolactone carcinogenic for mouse skin?
Conclusion
Beta-propiolactone is carcinogenic for mouse skin, with tumors appearing after repeated applications.
Supporting Evidence
- Papillomata began to appear after 27 applications of beta-propiolactone.
- Three tumors appeared alongside a scar after high concentrations of beta-propiolactone were applied.
- Single intravenous injections of beta-propiolactone did not increase lung tumor incidence.
Takeaway
This study found that a chemical called beta-propiolactone can cause skin tumors in mice, especially when applied repeatedly.
Methodology
Mice were treated with beta-propiolactone and croton oil, and their skin was examined for tumor formation.
Limitations
The study did not explore the long-term effects beyond 30 weeks for some mice.
Participant Demographics
Male and female stock albino mice of the 'S' strain were used.
Want to read the original?
Access the complete publication on the publisher's website